Author:
Mohammadkhani Niloufar,Gharbi Sedigheh,Rajani Huda Fatima,Farzaneh Avishan,Mahjoob Golnoosh,Hoseinsalari Afsaneh,Korsching Eberhard
Funder
Westfaelian Wilhelms University Münster, Germany
Reference114 articles.
1. Statin use and the risk of kidney disease with long-term follow-up (8.4-year study);Acharya;Am. J. Cardiol.,2016
2. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent;Alberts;Proc. Natl. Acad. Sci.,1980
3. Statins are potential anticancerous agents (review);Altwairgi;Oncol. Rep.,2015
4. Statins role in preventing contrast-induced acute kidney injury: a scoping review;Anjum;Hong Kong Med. J.,2019
5. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk;Athyros;Expet Panel Statement. Metabol.,2017
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献